EMS Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 31, 2025, 7:50 pm

Market Cap	3,319 Cr.
Current Price	598
High / Low	1,017/392
Stock P/E	18.1
Book Value	176
Dividend Yield	0.33 %
ROCE	26.6 %
ROE	20.7 %
Face Value	10.0
PEG Ratio	1.80

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for EMS Ltd

Competitors of EMS Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
EMS Ltd	3,319 Cr.	598	1,017/392	18.1	176	0.33 %	26.6 %	20.7 %	10.0
Industry Average	3,319.00 Cr	598.00		18.10	176.00	0.33%	26.60%	20.70%	10.00

All Competitor Stocks of EMS Ltd

Quarterly Result

Metric	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	121	151	190	138	211	200	245	206	233	245	266
Expenses	78	109	143	106	154	153	178	156	165	174	205
Operating Profit	43	43	48	32	57	47	68	50	69	71	61
OPM %	36%	28%	25%	23%	27%	23%	28%	24%	29%	29%	23%
Other Income	2	1	2	1	8	6	1	2	2	3	6
Interest	1	1	1	2	2	1	2	1	1	1	2
Depreciation	1	1	1	1	1	1	3	2	2	3	3
Profit before tax	43	42	48	31	62	51	64	49	67	70	63
Tax %	31%	28%	25%	25%	26%	26%	26%	25%	26%	27%	25%
Net Profit	30	30	36	23	45	37	47	37	50	51	47
EPS in Rs					8.15	6.72	8.53	6.68	8.94	9.09	8.39

Last Updated: May 31, 2025, 6:09 am

Below is a detailed analysis of the quarterly data for EMS Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 266.00 Cr.. The value appears strong and on an upward trend. It has increased from 245.00 Cr. (Dec 2024) to 266.00 Cr., marking an increase of 21.00 Cr..
For Expenses, as of Mar 2025, the value is 205.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 174.00 Cr. (Dec 2024) to 205.00 Cr., marking an increase of 31.00 Cr..
For Operating Profit, as of Mar 2025, the value is 61.00 Cr.. The value appears to be declining and may need further review. It has decreased from 71.00 Cr. (Dec 2024) to 61.00 Cr., marking a decrease of 10.00 Cr..
For OPM %, as of Mar 2025, the value is 23.00%. The value appears to be declining and may need further review. It has decreased from 29.00% (Dec 2024) to 23.00%, marking a decrease of 6.00%.
For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Dec 2024) to 6.00 Cr., marking an increase of 3.00 Cr..
For Interest, as of Mar 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Dec 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
For Depreciation, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 3.00 Cr..
For Profit before tax, as of Mar 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 70.00 Cr. (Dec 2024) to 63.00 Cr., marking a decrease of 7.00 Cr..
For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Dec 2024) to 25.00%, marking a decrease of 2.00%.
For Net Profit, as of Mar 2025, the value is 47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Dec 2024) to 47.00 Cr., marking a decrease of 4.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 8.39. The value appears to be declining and may need further review. It has decreased from 9.09 (Dec 2024) to 8.39, marking a decrease of 0.70.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 3:38 am

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	326	331	360	538	793	930
Expenses	230	232	247	388	589	673
Operating Profit	96	99	113	150	204	258
OPM %	30%	30%	31%	28%	26%	28%
Other Income	7	5	3	5	16	8
Interest	3	4	6	4	6	5
Depreciation	2	2	3	3	7	10
Profit before tax	98	98	107	148	207	250
Tax %	26%	27%	27%	26%	26%
Net Profit	72	72	79	109	153	185
EPS in Rs					27.44	33.24
Dividend Payout %	-0%	-0%	-0%	-0%	7%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	0.00%	9.72%	37.97%	40.37%
Change in YoY Net Profit Growth (%)	0.00%	9.72%	28.25%	2.39%

EMS Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 4 years from 2020-2021 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	24%
3 Years:	39%
TTM:	22%

Compounded Profit Growth
10 Years:	%
5 Years:	20%
3 Years:	33%
TTM:	24%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	24%

Return on Equity
10 Years:	%
5 Years:	23%
3 Years:	22%
Last Year:	21%

Last Updated: Unknown

Balance Sheet

Last Updated: January 13, 2025, 1:47 pm

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	12	12	12	47	56	56
Reserves	218	290	368	444	743	829
Borrowings	16	4	4	45	71	79
Other Liabilities	62	73	119	103	101	118
Total Liabilities	308	378	503	639	970	1,082
Fixed Assets	31	36	51	54	94	97
CWIP	0	3	0	4	0	0
Investments	0	0	1	2	10	18
Other Assets	276	340	451	579	866	967
Total Assets	308	378	503	639	970	1,082

Below is a detailed analysis of the balance sheet data for EMS Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is 56.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 56.00 Cr..
For Reserves, as of Sep 2024, the value is 829.00 Cr.. The value appears strong and on an upward trend. It has increased from 743.00 Cr. (Mar 2024) to 829.00 Cr., marking an increase of 86.00 Cr..
For Borrowings, as of Sep 2024, the value is 79.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 71.00 Cr. (Mar 2024) to 79.00 Cr., marking an increase of 8.00 Cr..
For Other Liabilities, as of Sep 2024, the value is 118.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 101.00 Cr. (Mar 2024) to 118.00 Cr., marking an increase of 17.00 Cr..
For Total Liabilities, as of Sep 2024, the value is 1,082.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 970.00 Cr. (Mar 2024) to 1,082.00 Cr., marking an increase of 112.00 Cr..
For Fixed Assets, as of Sep 2024, the value is 97.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Mar 2024) to 97.00 Cr., marking an increase of 3.00 Cr..
For CWIP, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Investments, as of Sep 2024, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 18.00 Cr., marking an increase of 8.00 Cr..
For Other Assets, as of Sep 2024, the value is 967.00 Cr.. The value appears strong and on an upward trend. It has increased from 866.00 Cr. (Mar 2024) to 967.00 Cr., marking an increase of 101.00 Cr..
For Total Assets, as of Sep 2024, the value is 1,082.00 Cr.. The value appears strong and on an upward trend. It has increased from 970.00 Cr. (Mar 2024) to 1,082.00 Cr., marking an increase of 112.00 Cr..

Notably, the Reserves (829.00 Cr.) exceed the Borrowings (79.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	47	36	23	4	-116
Cash from Investing Activity +	-27	-8	-15	-21	-70
Cash from Financing Activity +	-6	-11	3	38	176
Net Cash Flow	15	16	11	21	-9

Free Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	80.00	95.00	109.00	105.00	133.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	44	103	160	84	112
Inventory Days
Days Payable
Cash Conversion Cycle	44	103	160	84	112
Working Capital Days	127	184	219	137	156
ROCE %		37%	33%	33%	29%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	69.70%	69.70%	69.70%	69.70%	69.70%	69.70%
FIIs	7.23%	4.09%	2.78%	0.88%	0.75%	0.66%
DIIs	1.78%	1.45%	1.43%	1.58%	1.08%	0.40%
Public	21.28%	24.75%	26.08%	27.84%	28.46%	29.24%
No. of Shareholders	46,765	38,767	43,841	58,971	94,855	1,14,561

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Navi Flexi Cap Fund	30,000	0.91	2.51	30,000	2025-04-22 17:25:12	0%
Navi Aggressive Hybrid Fund	21,500	1.63	1.8	21,500	2025-04-22 17:25:12	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	29.38	23.16	67.27	61.24	61.62
Diluted EPS (Rs.)	29.38	23.16	67.27	61.24	61.62
Cash EPS (Rs.)	28.67	23.88	69.32	62.68	62.98
Book Value[Excl.RevalReserv]/Share (Rs.)	144.16	104.86	324.36	257.09	195.74
Book Value[Incl.RevalReserv]/Share (Rs.)	144.16	104.86	324.36	257.09	195.74
Revenue From Operations / Share (Rs.)	142.86	114.50	306.26	281.45	277.14
PBDIT / Share (Rs.)	39.55	33.00	98.52	88.83	87.46
PBIT / Share (Rs.)	38.37	32.28	96.37	87.36	86.13
PBT / Share (Rs.)	37.24	31.46	91.48	83.57	83.66
Net Profit / Share (Rs.)	27.49	23.16	67.17	61.20	61.65
NP After MI And SOA / Share (Rs.)	27.44	22.91	66.51	61.18	61.65
PBDIT Margin (%)	27.68	28.82	32.16	31.56	31.55
PBIT Margin (%)	26.85	28.19	31.46	31.03	31.07
PBT Margin (%)	26.06	27.47	29.87	29.69	30.18
Net Profit Margin (%)	19.24	20.22	21.93	21.74	22.24
NP After MI And SOA Margin (%)	19.20	20.01	21.71	21.73	22.24
Return on Networth / Equity (%)	19.09	21.94	20.55	23.80	31.49
Return on Capital Employeed (%)	24.18	26.92	28.74	32.87	40.72
Return On Assets (%)	15.70	16.78	15.55	19.00	23.51
Long Term Debt / Equity (X)	0.08	0.09	0.01	0.01	0.05
Total Debt / Equity (X)	0.08	0.09	0.01	0.01	0.06
Asset Turnover Ratio (%)	0.98	0.94	0.00	0.90	0.00
Current Ratio (X)	6.14	5.41	3.82	4.54	3.76
Quick Ratio (X)	5.14	4.06	3.32	4.00	3.04
Dividend Payout Ratio (NP) (%)	3.64	0.00	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	3.49	0.00	0.00	0.00	0.00
Earning Retention Ratio (%)	96.36	0.00	0.00	0.00	0.00
Cash Earning Retention Ratio (%)	96.51	0.00	0.00	0.00	0.00
Interest Coverage Ratio (X)	34.95	40.38	20.15	23.44	35.43
Interest Coverage Ratio (Post Tax) (X)	25.29	29.34	14.74	17.15	25.97
Enterprise Value (Cr.)	2183.92	0.00	0.00	0.00	0.00
EV / Net Operating Revenue (X)	2.75	0.00	0.00	0.00	0.00
EV / EBITDA (X)	9.94	0.00	0.00	0.00	0.00
MarketCap / Net Operating Revenue (X)	2.81	0.00	0.00	0.00	0.00
Retention Ratios (%)	96.35	0.00	0.00	0.00	0.00
Price / BV (X)	2.79	0.00	0.00	0.00	0.00
Price / Net Operating Revenue (X)	2.81	0.00	0.00	0.00	0.00
EarningsYield	0.06	0.00	0.00	0.00	0.00

After reviewing the key financial ratios for EMS Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 29.38. This value is within the healthy range. It has increased from 23.16 (Mar 23) to 29.38, marking an increase of 6.22.
For Diluted EPS (Rs.), as of Mar 24, the value is 29.38. This value is within the healthy range. It has increased from 23.16 (Mar 23) to 29.38, marking an increase of 6.22.
For Cash EPS (Rs.), as of Mar 24, the value is 28.67. This value is within the healthy range. It has increased from 23.88 (Mar 23) to 28.67, marking an increase of 4.79.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 144.16. It has increased from 104.86 (Mar 23) to 144.16, marking an increase of 39.30.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 144.16. It has increased from 104.86 (Mar 23) to 144.16, marking an increase of 39.30.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 142.86. It has increased from 114.50 (Mar 23) to 142.86, marking an increase of 28.36.
For PBDIT / Share (Rs.), as of Mar 24, the value is 39.55. This value is within the healthy range. It has increased from 33.00 (Mar 23) to 39.55, marking an increase of 6.55.
For PBIT / Share (Rs.), as of Mar 24, the value is 38.37. This value is within the healthy range. It has increased from 32.28 (Mar 23) to 38.37, marking an increase of 6.09.
For PBT / Share (Rs.), as of Mar 24, the value is 37.24. This value is within the healthy range. It has increased from 31.46 (Mar 23) to 37.24, marking an increase of 5.78.
For Net Profit / Share (Rs.), as of Mar 24, the value is 27.49. This value is within the healthy range. It has increased from 23.16 (Mar 23) to 27.49, marking an increase of 4.33.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 27.44. This value is within the healthy range. It has increased from 22.91 (Mar 23) to 27.44, marking an increase of 4.53.
For PBDIT Margin (%), as of Mar 24, the value is 27.68. This value is within the healthy range. It has decreased from 28.82 (Mar 23) to 27.68, marking a decrease of 1.14.
For PBIT Margin (%), as of Mar 24, the value is 26.85. This value exceeds the healthy maximum of 20. It has decreased from 28.19 (Mar 23) to 26.85, marking a decrease of 1.34.
For PBT Margin (%), as of Mar 24, the value is 26.06. This value is within the healthy range. It has decreased from 27.47 (Mar 23) to 26.06, marking a decrease of 1.41.
For Net Profit Margin (%), as of Mar 24, the value is 19.24. This value exceeds the healthy maximum of 10. It has decreased from 20.22 (Mar 23) to 19.24, marking a decrease of 0.98.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 19.20. This value is within the healthy range. It has decreased from 20.01 (Mar 23) to 19.20, marking a decrease of 0.81.
For Return on Networth / Equity (%), as of Mar 24, the value is 19.09. This value is within the healthy range. It has decreased from 21.94 (Mar 23) to 19.09, marking a decrease of 2.85.
For Return on Capital Employeed (%), as of Mar 24, the value is 24.18. This value is within the healthy range. It has decreased from 26.92 (Mar 23) to 24.18, marking a decrease of 2.74.
For Return On Assets (%), as of Mar 24, the value is 15.70. This value is within the healthy range. It has decreased from 16.78 (Mar 23) to 15.70, marking a decrease of 1.08.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.08, marking a decrease of 0.01.
For Total Debt / Equity (X), as of Mar 24, the value is 0.08. This value is within the healthy range. It has decreased from 0.09 (Mar 23) to 0.08, marking a decrease of 0.01.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.98. It has increased from 0.94 (Mar 23) to 0.98, marking an increase of 0.04.
For Current Ratio (X), as of Mar 24, the value is 6.14. This value exceeds the healthy maximum of 3. It has increased from 5.41 (Mar 23) to 6.14, marking an increase of 0.73.
For Quick Ratio (X), as of Mar 24, the value is 5.14. This value exceeds the healthy maximum of 2. It has increased from 4.06 (Mar 23) to 5.14, marking an increase of 1.08.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 3.64. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 3.64, marking an increase of 3.64.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 3.49. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 3.49, marking an increase of 3.49.
For Earning Retention Ratio (%), as of Mar 24, the value is 96.36. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 96.36, marking an increase of 96.36.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 96.51. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 96.51, marking an increase of 96.51.
For Interest Coverage Ratio (X), as of Mar 24, the value is 34.95. This value is within the healthy range. It has decreased from 40.38 (Mar 23) to 34.95, marking a decrease of 5.43.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 25.29. This value is within the healthy range. It has decreased from 29.34 (Mar 23) to 25.29, marking a decrease of 4.05.
For Enterprise Value (Cr.), as of Mar 24, the value is 2,183.92. It has increased from 0.00 (Mar 23) to 2,183.92, marking an increase of 2,183.92.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.75. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 2.75, marking an increase of 2.75.
For EV / EBITDA (X), as of Mar 24, the value is 9.94. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 9.94, marking an increase of 9.94.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.81. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 2.81, marking an increase of 2.81.
For Retention Ratios (%), as of Mar 24, the value is 96.35. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 96.35, marking an increase of 96.35.
For Price / BV (X), as of Mar 24, the value is 2.79. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 2.79, marking an increase of 2.79.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.81. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 2.81, marking an increase of 2.81.
For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 23) to 0.06, marking an increase of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of EMS Ltd as of June 1, 2025 is: 529.28

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 1, 2025, EMS Ltd is Overvalued by 11.49% compared to the current share price 598.00

Intrinsic Value of EMS Ltd as of June 1, 2025 is: 582.54

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 1, 2025, EMS Ltd is Overvalued by 2.59% compared to the current share price 598.00

Last 5 Year EPS CAGR: 10.06%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 26.40%, which is a positive sign. The company has higher reserves (482.00 cr) compared to borrowings (36.50 cr), indicating strong financial stability. The company has shown consistent growth in sales (546.33 cr) and profit (151.33 cr) over the years.	The stock has a high average Working Capital Days of 164.60, which may not be favorable. The stock has a high average Cash Conversion Cycle of 100.60, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in EMS Ltd:
1. Net Profit Margin: 19.24%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 24.18% (Industry Average ROCE: 26.6%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 19.09% (Industry Average ROE: 20.7%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 25.29
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 5.14
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 18.1 (Industry average Stock P/E: 18.1)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.08
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

EMS Ltd. is a Public Limited Listed company incorporated on 21/12/2010 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L45205DL2010PLC211609 and registration number is 211609. Currently Company is involved in the business activities of Water collection, treatment and supply. Company's Total Operating Revenue is Rs. 719.36 Cr. and Equity Capital is Rs. 55.53 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Water Supply & Management	701, DLF Tower A, New Delhi Delhi 110025	cs@ems.co.in http://www.ems.co.in

Management
Name	Position Held
Mr. Ramveer Singh	Chairman & Director
Mr. Ashish Tomar	Managing Director & CFO
Mrs. Kritika Tomar	Whole Time Director
Ms. Swati Jain	Ind. Non-Executive Director
Mr. Mukesh Garg	Ind. Non-Executive Director
Mrs. Chetna	Ind. Non-Executive Director
Mr. Achal Kapoor	Ind. Non-Executive Director

FAQ

What is the intrinsic value of EMS Ltd?

EMS Ltd's intrinsic value (as of 31 May 2025) is ₹529.28 — 11.49% lower the current market price of 598.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,319 Cr. market cap, FY2025-2026 high/low of ₹1,017/392, reserves of 829 Cr, and liabilities of 1,082 Cr.

What is the Market Cap of EMS Ltd?

The Market Cap of EMS Ltd is 3,319 Cr..

What is the current Stock Price of EMS Ltd as on 31 May 2025?

The current stock price of EMS Ltd as on 31 May 2025 is 598.

What is the High / Low of EMS Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of EMS Ltd stocks is ₹1,017/392.

What is the Stock P/E of EMS Ltd?

The Stock P/E of EMS Ltd is 18.1.

What is the Book Value of EMS Ltd?

The Book Value of EMS Ltd is 176.

What is the Dividend Yield of EMS Ltd?

The Dividend Yield of EMS Ltd is 0.33 %.

What is the ROCE of EMS Ltd?

The ROCE of EMS Ltd is 26.6 %.

What is the ROE of EMS Ltd?

The ROE of EMS Ltd is 20.7 %.

What is the Face Value of EMS Ltd?

The Face Value of EMS Ltd is 10.0.